SARA EARLY: Open Payments
NPI 1770190514 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,246 in 68 payments from 28 companies in 2025. Trend: 2023 $828 · 2024 $1,896 · 2025 $1,246
Food & beverage: $1,177Education: $69
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 9 | $138 |
| PFIZER INC. | 10 | $135 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $112 |
| ABBVIE INC. | 4 | $91 |
| Astellas Pharma US Inc | 2 | $84 |
| AstraZeneca Pharmaceuticals LP | 5 | $80 |
| Lilly USA, LLC | 4 | $62 |
| Corcept Therapeutics | 2 | $56 |
| Gilead Sciences, Inc. | 2 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
Products named: CABENUVA, Kerendia, NURTEC ODT, MOUNJARO, Korlym, UBRELVY, CAPLYTA, AIRSUPRA.
Industry payments across NC — which companies pay providers there.
